VTYX logo

Ventyx Biosciences (VTYX)

Profile

Full Name

Ventyx Biosciences, Inc.

Ticker Symbol

VTYX

Exchange

NASDAQ

Country

United States

IPO

October 21, 2021

Indexes

Not included

Employees

79

Key Details

Price

$1.04(-1.89%)

Market cap

Last Dividend

-

TTM Dividend yield

-

Annual revenue

-

Annual EPS

-$1.97(+40.30% YoY)

PE ratio

-

Next earnings date

May 9, 2025

Next ex-dividend date

N/A

Next split date

N/A

Price

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Price Performance

Price Range

Capitalization

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Market cap

Shares Outstanding

Technical Indicators

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Dividend

Income Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

EPS

Profit

Expenses

EBIT & EBITDA

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Liabilities

Debt

Equity & Capital

Cash Flow Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

CAPEX

Free Cash Flow

Profitability Ratios

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Margins

ROA & ROE

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PB Ratio

PS Ratio

Enterprise value

EV/EBITDA

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Leverage

Risk & Stability

Analyst ratings

Recent major analysts updates

Jan 14, 25 HC Wainwright & Co.
Neutral
Nov 11, 24 HC Wainwright & Co.
Neutral
Nov 8, 24 Oppenheimer
Outperform
Oct 15, 24 HC Wainwright & Co.
Neutral
Sep 23, 24 HC Wainwright & Co.
Neutral
Aug 12, 24 Wells Fargo
Overweight
Aug 12, 24 Canaccord Genuity
Buy
Jul 30, 24 HC Wainwright & Co.
Neutral
Jun 13, 24 HC Wainwright & Co.
Neutral
Jun 6, 24 Oppenheimer
Outperform

Institutional Ownership

  • What is the ticker symbol for Ventyx Biosciences?
  • Does Ventyx Biosciences pay dividends?
  • What sector is Ventyx Biosciences in?
  • What industry is Ventyx Biosciences in?
  • What country is Ventyx Biosciences based in?
  • When did Ventyx Biosciences go public?
  • Is Ventyx Biosciences in the S&P 500?
  • Is Ventyx Biosciences in the NASDAQ 100?
  • Is Ventyx Biosciences in the Dow Jones?
  • When was Ventyx Biosciences's last earnings report?
  • When does Ventyx Biosciences report earnings?
  • Should I buy Ventyx Biosciences stock now?

What is the ticker symbol for Ventyx Biosciences?

The ticker symbol for Ventyx Biosciences is NASDAQ:VTYX

Does Ventyx Biosciences pay dividends?

No, Ventyx Biosciences does not pay dividends

What sector is Ventyx Biosciences in?

Ventyx Biosciences is in the Healthcare sector

What industry is Ventyx Biosciences in?

Ventyx Biosciences is in the Biotechnology industry

What country is Ventyx Biosciences based in?

Ventyx Biosciences is headquartered in United States

When did Ventyx Biosciences go public?

Ventyx Biosciences's initial public offering (IPO) was on October 21, 2021

Is Ventyx Biosciences in the S&P 500?

No, Ventyx Biosciences is not included in the S&P 500 index

Is Ventyx Biosciences in the NASDAQ 100?

No, Ventyx Biosciences is not included in the NASDAQ 100 index

Is Ventyx Biosciences in the Dow Jones?

No, Ventyx Biosciences is not included in the Dow Jones index

When was Ventyx Biosciences's last earnings report?

Ventyx Biosciences's most recent earnings report was on Feb 27, 2025

When does Ventyx Biosciences report earnings?

The next expected earnings date for Ventyx Biosciences is May 9, 2025

Should I buy Ventyx Biosciences stock now?

As of today, analysts generally recommend a 'Buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions
On this page